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Background: Chronic obstructive pulmonary disease (COPD) is characterized by excessive inflammation and
disturbed bacterial clearance in the airways. Although cigarette smoke (CS) exposure poses a major risk, vitamin D
deficiency could potentially contribute to COPD progression. Many in vitro studies demonstrate important
anti-inflammatory and antibacterial effects of vitamin D, but a direct contribution of vitamin D deficiency to COPD
onset and disease progression has not been explored.
Methods: In the current study, we used a murine experimental model to investigate the combined effect of
vitamin D deficiency and CS exposure on the development of COPD-like characteristics. Therefore, vitamin D
deficient or control mice were exposed to CS or ambient air for a period of 6 (subacute) or 12 weeks (chronic).
Besides lung function and structure measurements, we performed an in depth analysis of the size and composition
of the cellular infiltrate in the airways and lung parenchyma and tested the ex vivo phagocytic and oxidative burst
capacity of alveolar macrophages.
Results: Vitamin D deficient mice exhibited an accelerated lung function decline following CS exposure compared
to control mice. Furthermore, early signs of emphysema were only observed in CS-exposed vitamin D deficient
mice, which was accompanied by elevated levels of MMP-12 in the lung. Vitamin D deficient mice showed
exacerbated infiltration of inflammatory cells in the airways and lung parenchyma after both subacute and chronic
CS exposure compared to control mice. Furthermore, elevated levels of typical proinflammatory cytokines and
chemokines could be detected in the bronchoalveolar lavage fluid (KC and TNF-α) and lung tissue (IP-10, MCP-1,
IL-12) of CS-exposed vitamin D deficient mice compared to control mice. Finally, although CS greatly impaired the
ex vivo phagocytic and oxidative burst function of alveolar macrophages, vitamin D deficient mice did not feature
an additional defect.
Conclusions: Our data demonstrate that vitamin D deficiency both accelerates and aggravates the development of
characteristic disease features of COPD. As vitamin D deficiency is highly prevalent, large randomized trials exploring
effects of vitamin D supplementation on lung function decline and COPD onset are needed.* Correspondence: wim.janssens@uzleuven.be
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Chronic obstructive pulmonary disease (COPD) is a
chronic disease characterized by a progressive expira-
tory airflow limitation and is associated with chronic
inflammation in the airways and lung parenchyma
[1]. In the majority of cases, this inflammatory re-
sponse in COPD is initiated by long-term exposure to
cigarette smoke (CS), which triggers a series of events
that damage the airways and terminal airspaces, leading
to lung function decline and emphysema. With pro-
gression of the disease, COPD patients become more
susceptible to exacerbations, a flaring-up of the disease
primarily induced by respiratory bacterial and viral
infections [2]. Exacerbations are an important cause of
hospitalization, reduced quality of life and mortality.
Interestingly, epidemiological evidence suggests a
role for vitamin D deficiency in COPD onset and pro-
gression. We and others previously demonstrated that
vitamin D deficiency (defined as serum 25-hydroxyvita-
min D (25OHD) < 20 ng/ml) is highly prevalent in COPD
patients and furthermore correlates with disease severity
(as assessed by the forced expiratory volume in 1 s
(FEV1)) [3–5]. In addition, associations have been
made between low serum 25OHD levels and charac-
teristic disease features of COPD, including reduced
lung function (FEV1 and forced vital capacity (FVC))
[3, 6, 7], faster lung function decline [8], severity of
CT-defined emphysema [9] and risk at COPD exacer-
bations [10]. However, evidence from epidemiological
studies remains conflicting as different negative stud-
ies have been published showing absence of associa-
tions [11–14]. The controversy remains high as many
of the pathogenic processes of COPD progression, such
as pulmonary inflammation, oxidative stress, parenchy-
mal destruction (emphysema) as well as defective anti-
bacterial responses can be counteracted in vitro by the
active form of vitamin D (1,25-dihydroxyvitamin D
(1,25(OH)2D)) [15]. For example, 1,25(OH)2D may pro-
mote antibacterial defense by enhancing phagocytosis,
oxidative burst, chemotaxis as well as production of anti-
microbial peptides [16, 17], while impeding excessive pro-
duction of inflammatory cytokines in airway epithelial
cells, monocytes, macrophages and dendritic cells [18–
22]. 1,25(OH)2D also inhibits the expression of several
matrix metalloproteinases (MMPs) [23, 24], which con-
tribute to parenchymal destruction.
Taken together, the direct impact of vitamin D defi-
ciency on CS-induced inflammation and the develop-
ment of COPD remains unclear. To directly address
these issues, we investigated the effect of vitamin D
deficiency on i) lung function and structure, ii) pul-
monary inflammation and iii) alveolar macrophage
antibacterial function in a mouse model of subacute
and chronic CS exposure.Methods
Animals
C57Bl/6J mice were purchased from Harlan. 3-weeks-
old male and female C57Bl/6J mice were fed with either
a vitamin D deficient diet (containing <100 IU/kg) or
a control diet (1000 IU/kg) (Ssniff ) (Bio-services;
Netherlands) and kept in UV light-free surroundings.
By the age of 8 weeks, breeding pairs were formed. Their
male offspring was used in this study and received the
same vitamin D deficient or control diet. All mice were
housed in UV light-free surroundings in a conventional
animal house with a 12/12 h light–dark cycle. Animals
were placed in filter-top cages and supplied with pelleted
food and water ad libitum. All experiments were approved
by the Ethical Committee of Animal Experiments of the
KU Leuven (P099/2011).
Cigarette smoke exposure
Vitamin D deficient or control mice were randomly di-
vided into 2 separate groups: CS-exposed groups and
air-exposed groups. Animals were exposed to CS (3R4F
research cigarettes with filter, Kentucky Tobacco Re-
search and Development Center, University of Kentucky)
using a nose-only exposure system (InExpose System,
Scireq). Mice were placed in soft restraints and con-
nected to a smoke-exposure tower. Computer-controlled
puffs were generated every minute, leading to 10 s of CS
exposure followed by 50 s of fresh air. At 8 weeks of age,
mice were acclimatized to CS by gradually increasing
the amount of cigarettes during the first 2 weeks of the
experiment. Afterwards, animals were exposed to 4 ciga-
rettes, twice a day, 5 days per week, for a period of
6 weeks (subacute) or 12 weeks (chronic). Similarly, con-
trol mice were put into soft restraints, but were exposed
to ambient air for the same period of time. The total
particulate density was measured daily and mice were
weighed weekly to monitor health conditions of the
animals.
Lung function
Twenty-four hours after the last CS exposure, mice
were anaesthetized intraperitoneally with a mixture of
xylazine (8,5 mg/kg, Rompun, Bayer, Belgium) and keta-
mine (130 mg/kg, Ketalar, Pfizer, Belgium). Tracheotomy
was performed with a standard catheter (CNS5002)
provided by the Buxco system. Mice were placed in a
whole-body plethysmograph and connected to a computer-
controlled ventilator (Buxco-Forced Pulmonary Maneu-
vers). Three different maneuvers were performed: the
Boyle’s law FRC maneuver, the quasi-static pressure
volume maneuver and the fast flow volume maneuver,
as previously described [25]. The Boyle’s law FRC man-
euver measures the functional residual capacity (FRC),
while the quasi-static pressure volume maneuver measures
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spiratory capacity (IC), vital capacity (VC) as well as the
quasi-static lung compliance (Cchord), which is defined as
the volume-pressure ratio at 50 % of expiration. The fast
volume maneuver determines dynamic lung volumes, such
as FVC and forced expiratory volume in 100 ms (FEV0.1).
Bronchoalveolar lavage and lung histology
After lung function measurements, mice were eutha-
nized by an intracardiac administration of pentobarbital
(Ceva, Brussels, Belgium). Bronchoalveolar lavage (BAL)
was performed with Hanks Balanced Salt Solution sup-
plemented with 10 mM HEPES. The supernatant of the
first BAL fraction was stored at −80 °C for cytokine and
chemokine analysis. Total cell count was performed
using a Neubauer hemocytometer. After ligation of the
right lung, the heart-left lung block was excised and
fixed in 6 % paraformaldehyde at a constant hydrostatic
pressure of 25 cm fluid column for 24 h. After dehydra-
tion and embedding in paraffin, sagittal sections were
stained with H&E. Airspace enlargement (emphysema)
was quantified by measuring the mean linear intercept
(Lm) in 15 randomly selected fields per lung slide, at
200X magnification. The Lm was calculated as the total
length of the grid lines x random fields divided by the
sum of the alveolar intercepts. A pathologist (E.V) semi-
quantitatively scored the parenchymal inflammation as
well as the severity of irregular airspace enlargement on
histological lung slices in a blinded manner.
Flowcytometric analysis of BAL cells
BAL cells were stained with fluorochrome-labeled mono-
clonal antibodies against CD4, CD8, CD11b, CD11c, Ly6C
and Ly6G (eBioscience) for 20 min at 4 °C. After washing,
samples were acquired on a Gallios flow cytometer
(Beckman Coulter, Brea, CA, USA) and analyzed with
the Kaluza software (Beckman Coulter). Alveolar mac-
rophages were identified as the CD11c+autofluorescenthigh
cell population, whereas neutrophils were identified as the
CD11c−CD11b+Ly6G+ cell population.
Alveolar macrophage antibacterial function
The ex vivo phagocytic and oxidative burst capacity of
alveolar macrophages was assessed by flow cytometry
using an adaptation of the commercial kit BURSTTEST
(Orpegen Pharma, Heidelberg, Germany). Briefly, BAL
cells were incubated for 2 h at 37 °C with pH-rodoRed-
labeled E. coli bacteria (pHrodo™ Red E. coli Bioparticles
Phagocytosis kit for flow cytometry, Invitrogen, Lennik,
Belgium), previously opsonized with E. coli BioParticles
opsonizing reagent (Invitrogen). After a 2-h incubation
at 37 °C, the fluorogenic substrate rhodamine was added.
Following 20 min of incubation at 37 °C, surface staining
of the alveolar macrophages was performed as describedabove. Samples were acquired on a Gallios flow cyt-
ometer (Beckman Coulter) and analyzed with the Kaluza
software (Beckman Coulter).
Pro-inflammatory cytokines and chemokines in the BAL fluid
Levels of IL-12p70, IL-6, KC, IL-10 and TNF-α in the
BAL fluid were measured using the mouse proinflamma-
tory panel 1 kit (Mesoscale Discovery, Gaithersburg,
MD, USA), according to the manufacturer’s instructions.
Data were acquired on a MESO QuickPlex SQ 120 sys-
tem and analyzed with the MSD Discovery Workbench
software (Mesoscale Discovery).
Quantification of relative mRNA levels
The right lung was snap-frozen in liquid nitrogen and
stored at −80 °C. Total RNA was extracted using the
RNeasy mini kit (Qiagen, Leudsen, Netherlands). A con-
stant amount of 1 μg of RNA was reverse transcribed
with Superscript III reverse transcriptase (Invitrogen)
and 5 mM oligo(dT)16 at 42 °C for 80 min. The qPCR
amplification reaction was performed on a StepOne™
real-time PCR system (Applied Biosystems, Carlsbad,
CA, USA) using the Fast (SYBR Green) Master Mix or
the TaqMan Fast Universal PCR Master Mix (Applied
Biosystems). The primer and Taqman probe sequences
used are shown in Table 1. Ribosomal protein L27 (RPL27)
was used as housekeeping gene. Data were analyzed using
the comparative cycle threshold (Ct) method.
Serum measurements
Blood was collected from the vena cava. Serum 25OHD
levels were measured by liquid-phase radioimmunoassay
(Diasorin, Stillwater, MN, USA). Calcium levels were de-
termined using an adaption of the Calcium Gen.2 kit
(Roche Diagnostics, Vilvoorde, Belgium). The intra-assay
coefficient of variation for 25OHD and calcium mea-
surements were 2.38 and 2.23 % respectively. The lower
detection limits were 1.5 ng/ml for 25OHD measure-
ments and 0.8 mg/dl for calcium measurements.
Statistical analysis
Data were analyzed using SAS software version 9.3 and
are presented as mean ± SEM. Statistical analysis was
performed using a two-way ANOVA at each timepoint
with a Tukey-Kramer post hoc test for multiple group
comparison. Differences were considered significant
when p-values were less than 0.05.
Results
The effect of vitamin D deficiency on serum 25OHD and
calcium levels
Lifelong feeding of C57Bl/6J mice with a control diet
(vitamin D sufficient) resulted in serum 25OHD concen-
trations of approximately 75–90 ng/ml, a level that is
Table 1 Primers used for quantitative PCR analysis
Target Sequence
RPL27 5′-GTCGAGATGGGCAAGTTCAT-3′ (FW)
5′-TTCTTCACGATGACGGCTTT-3′ (RV)
IP-10 5′-GCCGTCATTTTCTGCCTCAT-3′ (FW)
5′-GCTTCCCTATGGCCCTCATT-3′ (RV)
5′-TCTCGCAAGGACGGTCCGCTG-3′ (TP)
MCP-1 5′-CTTCTGGGCCTGCTGTTCA-3′ (FW)
5′-CCAGCCTACTCATTGGGATCA -3′ (RV)
5′-CTCAGCCAGATGCAGTTAACGCCCC-3′ (TP)
IL12p40 5′-GGAAGCACGGCAGCAGAATA-3′ (FW)
5′-AACTTGAGGGAGAAGTAGGAATGG-3′ (RV)
5′-CATCATCAAACCAGACCCGCCCAA-3′ (TP)
MMP-8 5′-CTTTCAACCAGGCCAAGGTA-3′ (FW)
5′-GAGCAGCCACGAGAAATAGG-3′ (RV)
MMP-9 5′-TTCCCCAAAGACCTGAAAAC-3′ (FW)
5′-TGCTTCTCTCCCATCATCTG-3′ (RV)
MMP-12 5′-TTTTGATGGCAAAGGTGGTA-3′ (FW)
5′-GCCTCATCAAAATGTGCATC-3′ (RV)
TIMP-1 5′-GTGGGAAATGCCGCAGAT-3′ (FW)
5′-GGGCATATCCACAGAGGCTTT-3′ (RV)
FW forward primer, RV reverse primer, TP Taqman probe
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by our facility (Table 2). Conversely, feeding of mice with
a vitamin D deficient diet from in utero until adulthood
significantly lowered serum 25OHD concentrations to
17–20 ng/ml. Serum calcium levels did not differ be-
tween vitamin D deficient or control mice (Table 2).
Moreover, both serum 25OHD and calcium levels were
similar after 6 and 12 weeks. None of the above parame-
ters were affected by CS exposure (Table 2).
Vitamin D deficiency accelerates lung function decline
following CS exposure
To investigate the effect of vitamin D deficiency on CS-
induced aberrations in the lungs, vitamin D deficient or
control mice entered a daily CS- or ambient air exposure
regimen for 6 weeks (subacute) or 12 weeks (chronic)
starting at the age of 8 weeks. After 6 weeks of CS expos-
ure, parameters indicating lung hyperinflation (TLC, com-
pliance, IC, VC, FVC and FEV0.1) remained unchanged in
control mice (Fig. 1 + Additional file 1). However, inTable 2 Serum 25-hydroxyvitamin D and calcium levels
Vitamin D deficient
Air-exposed CS-ex
25OHD (ng/ml) 19.76 ± 1.87a 17.37
Calcium (mg/dl) 9.71 ± 0.62 10.97
At the age of 8 weeks, C57Bl/6J vitamin D deficient and control mice were exposed
12 weeks and are represented as mean ± SEM.a p < 0.0001 vs air-exposed control;b pvitamin D deficient mice, signs of lung hyperinflation were
already detected after 6 weeks of CS exposure. This was
evident from a 23 % increase in TLC and a 24 % increase
in compliance (Fig. 1a-b). Similar trends were observed
for IC, VC, FEV0.1 and FVC (Additional file 1). Only after
chronic CS exposure, a trend towards hyperinflation of
the lungs was observed in control mice, as shown by an
increase in TLC (16 %) and compliance (12 %) (Fig. 1) as
well as IC, VC, FVC and FEV0.1 (Additional file 1). No
additional differences were observed after 12 weeks of
smoking in vitamin D deficient mice.
Vitamin D deficient mice feature early signs of emphysema
accompanied by elevated MMP-12 expression levels
following CS exposure
Figure 2a shows representative pictures of H&E-stained
sections of paraffinized left lungs of each experimental
group after 6 weeks of CS exposure. Emphysema was
quantified on histological lung slices by measuring the
mean linear intercept (Lm) as well as by scoring the irregu-
larity of airspace sizes. Based on the semi-quantitative
scores for the irregularity of airspace sizes, mild emphy-
sema was found to be present in vitamin D deficient mice
after already 6 and 12 weeks of smoking, but not in control
mice (Fig. 2a-b). This was however not reflected by signifi-
cant differences in Lm (Fig. 2c). Moreover, the increase in
mRNA expression levels of macrophage elastase (MMP-
12) due to CS exposure was more pronounced in vitamin
D deficient mice compared to control mice (Fig. 2d). How-
ever, no differences in the mRNA expression of MMP-8,
MMP-9 or TIMP-1 were observed (data not shown).
Vitamin D deficiency exacerbates airway inflammation
upon CS exposure
We next assessed the cumulative effect of vitamin D defi-
ciency on the size and composition of the airway inflam-
matory response to CS. Analysis of the bronchoalveolar
cell infiltrate revealed no significant differences in the
total cell number or in the number of CD11c+ auto-
fluorescenthigh alveolar macrophages after 6 and 12 weeks
of smoking, independently of vitamin D status (data not
shown). In control mice, a slight, non-significant increase
in neutrophils was observed after 6 and 12 weeks of CS
exposure (Fig. 3a). CS exposure dramatically exacerbated
airway neutrophilia in vitamin D deficient mice compared
to control mice to a similar extent at both subacute andControl
posed Air-exposed CS-exposed
± 2.68b 76.30 ± 3.15 86.76 ± 4.03
± 0.47 10.24 ± 0.26 9.09 ± 1.21
to CS or ambient air for a period of 6 or 12 weeks. Data show results after
< 0.0001 vs CS-exposed control
Fig. 1 Effect of vitamin D deficiency on lung function parameters in air- and CS-exposed mice after 6 and 12 weeks. At the age of 8 weeks,
C57Bl/6J vitamin D deficient and control mice were exposed to CS or ambient air for a period of 6 or 12 weeks. Lung function was measured
with whole-body plethysmography after 6 and 12 weeks of smoking. a The total lung capacity (TLC) and b lung compliance (Cchord). n = 10–12
per group per timepoint; mean ± SEM; *p < 0.05, **p < 0.01
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the neutrophil chemoattractant KC (mouse homolog
of IL-8) as well as TNF-α in the BAL fluid following 6
and 12 week of CS exposure was more pronounced in
vitamin D deficient mice compared to control mice
(Fig. 3b-c). Protein levels of IL-6, IL-10 and IL-12 remained
unchanged between the experimental groups (data not
shown). Airway infiltration with T lymphocytes (CD4+ and
CD8+ T cells) was only observed in vitamin D deficient
mice after 12 weeks of smoking (Fig. 3d-e).
Increased inflammation in the lung parenchyma of
vitamin D deficient mice following CS exposure
In addition to the extent of airway inflammation, parenchy-
mal inflammation was evaluated on H&E-stained sections
of paraffinized left lungs. Figure 4a shows representative
figures of each experimental group after 6 weeks of CS ex-
posure. A semiquantitative score was given based on the
presence of macrophages, neutrophils or lymphocytes. In
control mice, a mild increase in macrophages was ob-
served in CS-exposed mice after 6 and 12 weeks of smok-
ing (Fig. 4b). However, neutrophilic or lymphocytic
infiltration, either peribronchial or alveolar, was not ob-
served (Fig. 4c-d). Similar to control mice, neutrophilicinflammation was absent in the lung parenchyma of
vitamin D deficient mice. However, the increase in the
number of tissue macrophages due to CS exposure was
much more pronounced in vitamin D deficient mice com-
pared to control mice after 6 and 12 weeks (Fig. 4b). Low-
grade peribronchial and alveolar lymphocytic inflamma-
tion could only be detected in vitamin D deficient mice
after 6 and 12 weeks of smoking (Fig. 4a + c-d). As an
additional parameter of inflammation within the intersti-
tial lung tissue, relative mRNA levels of several inflamma-
tory cytokines and chemokines were determined in right
lung homogenates. Supporting a clear augmented inflam-
matory profile, the increase in expression levels of IL-
12, MCP-1 and IP-10 following CS exposure was more
pronounced in vitamin D deficient mice compared to
control mice (Fig. 5a-c).
Vitamin D deficiency only mildly affects CS–induced
defects of alveolar macrophage antibacterial function
To assess the effect of vitamin D deficiency on the anti-
bacterial functionality of alveolar macrophages in the con-
text of CS exposure, the ex vivo phagocytic and oxidative
burst capacity of alveolar macrophages was assessed fol-
lowing interaction of BAL cells with E. coli bacteria. CS
Fig. 2 Effect of vitamin D deficiency on lung structure in air- and CS-exposed mice after 6 and 12 weeks. At the age of 8 weeks, C57Bl/6J vitamin D
deficient and control mice were exposed to CS or ambient air for a period of 6 or 12 weeks. a Representative figures of H&E-stained lung
sections of paraffinized lungs of each experimental group (100X magnification) after 6 weeks of smoking. b The irregularity of airspaces
on histological lung sections was given a semi-quantitative score ranging from 0 to 3 by a pathologist in a blinded manner (0 = absent,
0.5 = minimal, 1 = mild, 2 = moderate and 3 = severe). c The mean linear intercept (Lm), as a measure of the interalveolar wall distance,
was determined on histological lung sections (at 200X magnification). The Lm was measured in 15 randomly selected fields per lung slide
and calculated as the total length of the grid lines x random fields divided by the sum of the alveolar intercepts. d Relative expression
levels of MMP-12 in lung homogenates, analyzed with RT-PCR. Data were normalized using RPL-27 as housekeeping gene and analyzed
with the comparative cycle threshold (Ct) method. n = 10–12 per group per timepoint; mean ± SEM; *p < 0.05, **p < 0.01, ****p < 0.0001
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alveolar macrophages to the same extent in both vitamin
D deficient and control mice after 6 and 12 weeks of
smoking (Fig. 6a). No additional effect of vitamin D defi-
ciency was observed on the phagocytic capacity of alveolar
macrophages. The production of reactive oxygen species
was also decreased upon CS exposure in vitamin D defi-
cient and control mice after 6 weeks (Fig. 6b). However,
vitamin D deficiency triggered a slight further impair-
ment of the CS-induced defect in oxidative burst
capacity only at the subacute stage of the disease.
Discussion
Vitamin D deficiency is highly common in COPD patients
[3–5] and increasing evidence suggests a role for vitamin Ddeficiency in COPD pathogenesis, which is characterized by
exacerbated airway and parenchymal inflammation as well
as defective antibacterial responses. Despite many in vitro
cell studies highlighting important anti-inflammatory and
antimicrobial effects of vitamin D, evidence from epi-
demiological studies remains contradictory. Therefore,
our aim was to investigate whether vitamin D deficiency
can directly influence characteristic features of COPD
pathogenesis in a mouse model of subacute and chronic
CS exposure. We show that vitamin D deficiency acceler-
ates lung function changes upon CS exposure consistent
with an increased lung compliance and TLC, early signs of
emphysema and enhanced expression of MMP-12. We
furthermore demonstrate that vitamin D deficiency leads
to exacerbated airway and parenchymal inflammation
Fig. 3 Effect of vitamin D deficiency on airway inflammation in air- and
CS-exposed mice after 6 and 12 weeks. At the age of 8 weeks, C57Bl/6J
vitamin D deficient and control mice were exposed to CS or
ambient air for a period of 6 or 12 weeks. The number of a
neutrophils (CD11c−CD11b+Ly6G+), d CD4+ T cells and e CD8+ T cells
was determined in the BAL fluid using flow cytometry. Data are
expressed as number of cells (×104) per milliliter of recovered BAL
fluid. Levels of b KC and c TNF-α were measured in the supernatant of
the BAL fluid. n = 10–12 per group per time point; mean ± SEM;
**p < 0.01, ***p < 0.001, ****p < 0.0001
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CS exposure. CS exposure was associated with strong de-
creases in antibacterial functionality of alveolar macro-
phages. However, vitamin D deficiency did not affect
bacterial phagocytosis in addition to CS, although minor
additional defects were observed in the oxidative burst
capacity after subacute CS exposure.
Whether vitamin D deficiency can directly influence
lung function or emphysema progression in long-term
smokers cannot be derived from observational studies
as reversed causation, even with longitudinal design,
cannot be excluded. Notwithstanding the shortcomings of
mouse models with smoke-induced emphysema, they offer
the advantage to explore causality by specific exposures.
To our knowledge, only one study has investigated the
effect of vitamin D deficiency on the development of
emphysema in a mouse model of CS exposure [26].
Crane-Godreau et al. found more severe emphysema
(as assessed by measurement of Lm) in vitamin D defi-
cient mice compared to control mice after 16 weeks of
smoking, without additional differences in lung func-
tion parameters (TLC and lung compliance). We extend
on these data by showing that vitamin D deficiency accel-
erates lung disease progression upon CS exposure. In this
context, hyperinflation of the lungs (as demonstrated by
increases in TLC, compliance, IC, VC, FEV0.1 and FVC)
was more pronounced in vitamin D deficient mice com-
pared to control mice after already 6 weeks of smoking.
However, after 12 weeks of smoking, hyperinflation of the
lungs was also observed in control mice, without an add-
itional effect of vitamin D deficiency. The increase in
FEV0.1 and FVC with smoking is however contradictory
to what is seen in human COPD but is explained by the
compliant chest wall of mice, which allows an unlimited
expansion of the lungs with positive pressure inflation and
consequently higher volumes and flows during expiration
[25]. We did not observe an effect of vitamin D deficiency
on lung function parameters in air-exposed mice, in the
absence of CS exposure after 6 or 12 weeks. This is in
contrast to the findings of Zosky et al., who found deficits
in lung function in the offspring (2 weeks of age) of vita-
min D deficient mice [27]. In our study, airspaces were
more heterogeneously enlarged in vitamin D deficient
mice after both subacute and chronic CS exposure com-
pared to control mice. These early signs of emphysema
may be (partially) explained by the increased expression of
MMP-12 in vitamin D deficient mice following CS expos-
ure. MMP-12 is a macrophage elastase which degrades
the extracellular matrix and weakens the interstitial al-
veolar structure, and has shown to be increased in
COPD patients [28, 29]. Furthermore, MMP-12 knock-
out mice were protected from CS-induced emphysema,
demonstrating an important role for MMP-12 in the
development of emphysema [30].
Fig. 4 Effect of vitamin D deficiency on parenchymal inflammation in air- and CS-exposed mice after 6 and 12 weeks. At the age of 8 weeks,
C57Bl/6J vitamin D deficient and control mice were exposed to CS or ambient air for a period of 6 or 12 weeks. a Representative figures of
H&E-stained lung sections of each experimental group (200X magnification) after 6 weeks of smoking. Full arrows show the presence of
peribronchial lymphocytic inflammation, while dashed arrows show the presence of pigmented macrophages in CS-exposed vitamin D deficient
mice. b The diffuse presence of macrophages and the presence of c alveolar and d peribronchial lymphocytic inflammation on histological lung
sections was given a semiquantitative score ranging from 0 to 3 by a pathologist in a blinded manner (0 = absent, 0.5 = minimal, 1 =mild,
2 =moderate and 3 = severe). n = 10–12 per group per time point; mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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exaggerated chronic inflammation in the lungs in response
to CS. This chronic inflammation is characterized by pul-
monary infiltration of inflammatory cells, such as neutro-
phils, macrophages and lymphocytes, and elevated levels
of (chemoattractant) cytokines, including TNF-α, IL-8,
MCP-1 and IP-10 [31]. Interestingly, the active form of
vitamin D, 1,25(OH)2D, has been shown to decrease the
expression of these proinflammatory cytokines and che-
mokines in several cell types, including macrophages, neu-
trophils and airway epithelial cells [18–22, 32], potentially
by interfering with the NF-κB and p38 MAP kinase in-
flammatory pathways. By downregulating the expression
of inflammatory cytokines and chemokines, vitamin D
could also indirectly influence the infiltration of inflamma-
tory cells into the lungs. Using our mouse model, we showfor the first time that CS exposure leads to exacerbated
airway and parenchymal inflammation in vitamin D defi-
cient mice compared to control mice, characterized by in-
creased inflammatory cell infiltration and enhanced
inflammatory mediators. The most prominent characteris-
tic of the CS-induced airway inflammation was the neu-
trophilic infiltration, which was clearly more pronounced
in vitamin D deficient mice and was accompanied by in-
creased levels of KC and TNF-α. In a study of Li and col-
leagues, vitamin D deficiency also enhanced neutrophil
infiltration into the lungs after challenge with A. fumigatus
[33]. Furthermore, in a mouse model of allergic airway
disease, it was shown that vitamin D deficiency enhances
airway neutrophilic inflammation, which was subsequently
suppressed after supplementation of vitamin D deficient
mice with vitamin D [34]. In an animal model of acute
Fig. 5 Effect of vitamin D deficiency on expression levels of proinflammatory cytokines and chemokines in lung tissue of air- and CS-exposed
mice after 6 and 12 weeks. At the age of 8 weeks, C57Bl/6J vitamin D deficient and control mice were exposed to CS or ambient air for a period
of 6 or 12 weeks. Relative expression levels of a IL-12, b MCP-1 and c IP-10 in lung homogenates were analyzed with RT-PCR. Data were
normalized using RPL-27 as housekeeping gene and analyzed with the comparative cycle threshold (Ct) method. n = 10–12 per group per time
point; mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
Fig. 6 Effect of vitamin D deficiency on the antibacterial function of
alveolar macrophages in air- and CS-exposed mice after 6 and
12 weeks. At the age of 8 weeks, C57Bl/6J vitamin D deficient and
control mice were exposed to CS or ambient air for a period of 6 or
12 weeks. The ex vivo phagocytic and oxidative burst capacity of
alveolar macrophages was assessed following interaction of BAL
cells with E. coli bacteria. a Percentage of alveolar macrophages
(CD11c+autofluorescenthigh) that have internalized E. coli bacteria.
b Percentage of alveolar macrophages (CD11c+autofluorescenthigh)
that have produced reactive oxygen radicals. n= 10–12 per group per
time point; mean ± SEM; *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001
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1,25(OH)2D also inhibited the recruitment of neutrophils
after LPS inhalation [35]. Knockout of the vitamin D re-
ceptor (VDR) in mice moreover resulted in increased in-
flammatory cell influx in the airways (neutrophils) and
lung parenchyma (macrophages), which was accompanied
by enhanced activity of NF-κB and elevated levels of
MCP-1 and KC in the lungs [36]. In our study, CS expos-
ure resulted in an increased number of macrophages in
the lung parenchyma of vitamin D deficient mice com-
pared to control mice. Furthermore, airway infiltration of
CD4+ and CD8+ T cells and low-grade lymphocytic paren-
chymal inflammation was exclusively observed in CS-
exposed vitamin D deficient mice. This was associated
with increased expression of MCP-1 and IP-10 in lung tis-
sue, which may explain the elevated infiltration of respect-
ively mononuclear cells and lymphocytes in the lung
parenchyma.
Defective antibacterial function of macrophages might
contribute to the persistence of respiratory infections and
consequently exacerbations in COPD patients [37, 38].
Several antibacterial functions have been attributed to
1,25(OH)2D, including stimulation of phagocytosis, oxida-
tive burst, chemotaxis and the production of antimicrobial
peptides in vitro [16, 17, 39, 40]. In our in vivo study we
evaluated for the first time whether vitamin D deficiency
can directly influence the antibacterial function of alveolar
macrophages in CS-exposed lungs. Our data confirm that
CS exposure leads to significant decreases in the ex vivo
phagocytic as well as oxidative burst functions of alveolar
Heulens et al. Respiratory Research  (2015) 16:110 Page 10 of 11macrophages. However, vitamin D deficiency did not fur-
ther affect the phagocytic function of alveolar macro-
phages. Our data confirm the findings of Giuletti et al. in
autoimmune diabetic NOD mice showing that vitamin D
deficiency did not alter the ex vivo chemotactic or phago-
cytic capacity of peritoneal macrophages [41]. Indirectly, it
may suggest that smoking, rather than a deficient vitamin
D status, increases the risk for infection in vivo, which
may explain why different human studies in COPD found
no associations between 25OHD status and risk for exac-
erbations [12–14]. We do acknowledge that we solely
assessed the ex vivo antibacterial functionality of alveolar
macrophages and that in vivo bacterial challenge would
offer more appropriate insights.
It should be noted that serum 25OHD levels in our
mouse model are not unambiguously comparable to the
human situation. In humans, serum 25OHD levels be-
tween 30 and 50 ng/ml are generally considered sufficient,
although 25OHD levels necessary for extra-calcemic func-
tions of vitamin D, including immunomodulation, are still
debatable. However, in our study, C57Bl/6 mice on the
control diet have serum 25OHD concentrations of ap-
proximately 75–90 ng/ml, which are already considerably
higher than sufficient levels in humans. These relatively
high 25OHD levels in control mice are comparable to
other mouse studies, where no systemic side-effects of
these 25OHD concentrations were observed [41, 42]. In
humans, vitamin D deficiency is defined as serum 25OHD
levels below 20 ng/ml, whereas levels below 10 ng/ml are
considered severely deficient, which is about 4-fold lower
than sufficient levels. In our mouse model, serum 25OHD
levels in vitamin D deficient mice (17–20 ng/ml) were also
approximately 4-fold lower compared to control mice
(75–90 ng/ml). Therefore, the 25OHD levels reached in
our vitamin D deficient mice may reflect a severely defi-
cient status in mice, although these levels are higher than
what other authors have used in models for vitamin D
deficiency [27, 34, 41].
Conclusions
In conclusion, we have shown that vitamin D deficiency
accelerates and aggravates the development of COPD-
like characteristics (lung function changes, emphysema
and pulmonary inflammation) in the lungs following
CS exposure, suggesting an important role for the vita-
min D pathway in COPD pathogenesis and progression.
Our data strengthen the epidemiological associations and
mechanistic in vitro studies that link vitamin D deficiency
to characteristic features of COPD. Two randomized
placebo-controlled intervention trials have already shown
the therapeutic benefit of vitamin D supplementation on
exacerbation risk in COPD patients with vitamin D
deficiency at baseline [43, 44]. As vitamin D deficiency
is highly prevalent, large preventive trials assessing theeffect of vitamin D supplementation on COPD onset
will provide even more insights into the role of vitamin D
deficiency in the development of COPD.
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